J. Carpenter

Verteporfin photodynamic therapy for neovascular age-related macular degeneration: cohort study for the UK.

C. Guerriero, S. Harding, R. Grieve, 2012, Health technology assessment.

Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results.

L. Smeeth, S. Schneeweiss, I. Douglas, 2021, Health technology assessment.

Estimation of admixture and detection of linkage in admixed populations by a Bayesian approach: application to African‐American populations

J. Carpenter, P. McKeigue, M. Shriver, 2000, Annals of human genetics.

Identification of risk factors by systematic review and development of risk-adjusted models for surgical site infection.

B. Reeves, D. Lamping, J. Bruce, 2011, Health technology assessment.

Two‐stage method to remove population‐ and individual‐level outliers from longitudinal data in a primary care database

I. White, J. Carpenter, K. Walters, 2012, Pharmacoepidemiology and drug safety.

Verteporfin photodynamic therapy cohort study: report 1: effectiveness and factors influencing outcomes.

S. Harding, R. Grieve, T. Peto, 2009, Ophthalmology.

Network Meta‐Analysis

Gerta Rücker, Guido Schwarzer, James R. Carpenter, 2015 .

a tool for assessing risk of bias in non-randomized studies

M. Hernán, P. Santaguida, J. Sterne, 2016 .